Real-time enrollment status for this glycogen storage disease type ii clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:40 AM UTC
| NCT Number | NCT00231400 |
| Recruiting Status | Recruiting |
| Condition | Glycogen Storage Disease Type II |
| Phase | Clinical Trial |
| Target Enrollment | 2,000 participants |
| Active Locations | 92 sites in the US |
| Sponsor | Genzyme, a Sanofi Company |
| Last Updated on CT.gov | June 23, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT00231400 is currently recruiting participants. This clinical trial study for glycogen storage disease type ii is actively seeking new participants at 92 locations across the United States. The study is sponsored by Genzyme, a Sanofi Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT00231400 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 92 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT00231400 was last updated 2 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.